Friday, March 27, 2020
Gilead halts emergency access to COVID-19 contender remdesivir amid 'overwhelming demand' Monday, March 23, 2020
Monday, March 23, 2020
Since the early days of the current coronavirus outbreak, Gilead Sciences’ experimental antiviral drug remdesivir has been hailed as a leading hope. That halo has apparently overwhelmed the Big Biotech, which has temporarily stopped granting patients emergency access to remdesivir due to an “exponential increase” in requests.